TY  - GEN
AU  - Sugimoto,Kayo
AU  - Kim,Soo Ryang
AU  - Kim,Soo Ki
AU  - Imoto,Susumu
AU  - Tohyama,Madoka
AU  - Kim,Ke Ih
AU  - Ohtani,Aya
AU  - Hatae,Takashi
AU  - Yano,Yoshihiko
AU  - Kudo,Masatoshi
AU  - Hayashi,Yoshitake
TI  - Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma
SN  - 1423-0232
PY  - 2016///0308
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - therapeutic use
KW  - Carbamates
KW  - Carcinoma, Hepatocellular
KW  - epidemiology
KW  - Drug Therapy, Combination
KW  - Female
KW  - Follow-Up Studies
KW  - Genotype
KW  - Hepacivirus
KW  - drug effects
KW  - Hepatitis C, Chronic
KW  - blood
KW  - Humans
KW  - Imidazoles
KW  - Interferon alpha-2
KW  - Interferon-alpha
KW  - Isoquinolines
KW  - Japan
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Neoplasm Staging
KW  - Oligopeptides
KW  - Polyethylene Glycols
KW  - Polymerase Chain Reaction
KW  - Prognosis
KW  - Pyrrolidines
KW  - RNA, Viral
KW  - genetics
KW  - Recombinant Proteins
KW  - Ribavirin
KW  - Simeprevir
KW  - Sulfonamides
KW  - Valine
KW  - analogs & derivatives
KW  - Viral Load
KW  - alpha-Fetoproteins
KW  - analysis
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1159/000440630
ER  -